Showing results (251-260 of 727) with videos related to

Sort By:
Pageof 73
Expert Opinion on Therapeutic Targets|January 18, 2007
Is YKL-40 a new therapeutic target in cancer?Julia S Johansen, Benny Vittrup Jensen, Anne Roslind, et al.
European Journal of Clinical Investigation|April 1, 1988
Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal womenJ S Johansen, B J Riis, P D Delmas, et al.
Forensic Science International|August 21, 2003
Fatal overdose of the herbicide bentazoneI B Müller, H Willads Petersen, S S Johansen, et al.
Infection|September 1, 1988
An international study on the occurrence of multiresistant bacteria and aminoglycoside consumption patternsK S Johansen, M Storgaard, N Carstensen, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
High serum YKL-40 level in patients with small cell lung cancer is related to early deathJulia S Johansen, Lars Drivsholm, Paul A Price, et al.
Scandinavian Journal of Rheumatology|December 1, 2001
Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destructionJ S Johansen, J R Kirwan, P A Price, et al.
The British Journal of Dermatology|May 1, 1981
Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous diseaseF Brandrup, C Koch, M Petri, et al.
Infectious Diseases (London, England)|March 3, 2025
Case series of Candida albicans spondylodiscitis and a brief review of the literatureNanna D Christiansen, Susan O Lindvig, Isik S Johansen, et al.
European Review for Medical and Pharmacological Sciences|January 20, 2022
A review on the forensic toxicology of global drug-facilitated sexual assaultsK Skov, S S Johansen, K Linnet, et al.
Metabolism: Clinical and Experimental|November 1, 1990
Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal womenJ S Johansen, S B Jensen, B J Riis, et al.
Pageof 73